InVivoMAb anti-mouse CD8 (Lyt 2.1)

Cao Y, Trillo-Tinoco J, Sierra RA, et al. ER stress-induced mediator C/EBP homologous protein thwarts effector T cell activity in tumors through T-bet repression. Nat Commun. 2019,10(1):1280. doi: 10.1038/s41467-019-09263-1

Wang M, Racine J, Zhang M, et al. MHC-mismatched chimerism is required for induction of transplantation tolerance in autoimmune nonobese diabetic recipients. J Immunol. 2014,193(4):2005-15. doi: 10.4049/jimmunol.1401137

Racine JJ, Wang M, Zhang M, et al. Induction of mixed chimerism depletes pre-existing and de novo-developed autoreactive B cells in autoimmune NOD mice. Diabetes. 2014,63(6):2051-62. doi: 10.2337/db13-1532

Yang Y, Liu C, Peng W, et al. Antitumor T-cell responses contribute to the effects of dasatinib on c-KIT mutant murine mastocytoma and are potentiated by anti-OX40. Blood. 2012,120(23):4533-43. doi: 10.1182/blood-2012-02-407163

Makhlouf L, Yamada A, Ito T, et al. Allorecognition and effector pathways of islet allograft rejection in normal versus nonobese diabetic mice. J Am Soc Nephrol. 2003,14(8):2168-75.

Kang ES, Iacomini J. Induction of central deletional T cell tolerance by gene therapy. J Immunol. 2002,169(4):1930-5.